Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Feng, Yumei ^a,b   Hans, Chetan ^c   McIlwain, Elizabeth ^a   Varner, Kurt J ^a   Lazartigues, Eric ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; COLLAGEN; NORADRENALIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL SIZE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HEMODYNAMICS; HYPERTENSION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TIBIA;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRAIN; CARDIOMEGALY; HEART; HEMODYNAMICS; MICE; NEURONS; NOREPINEPHRINE; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84869117662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048910     Document Type: Article

References (40)

1. Davisson RL, (2003) Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol- Regul Integr Comp Physiol 285: R498-R511.
2. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9.
3. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243.
4. Lazartigues E, Feng Y, Lavoie JL, (2007) The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Curr Pharm Des 13: 1231-1245.
5. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, et al. (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 292: R373-R381.
6. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, et al. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-14843.
7. Tallant EA, Ferrario CM, Gallagher PE, (2006) Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart. Future Cardiol 2: 335-342.
8. Ferrario CM, (2006) Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7): An Evolving Story in Cardiovascular Regulation. Hypertension 47: 515-521.
9. Diez-Freire C, Vazquez J, Correa de Adjounian MF, Ferrari MFR, Yuan L, et al. (2006) ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics 27: 12-19.
10. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, et al. (2004) Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44: 907-912.
11. Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, et al. (2005) Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp Physiol 90: 783-790.
12. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, et al. (2010) Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension. Circ Res 106: 373-382.
13. Cowan B, Young A, (2009) Left ventricular hypertrophy and renin-angiotensin system blockade. Curr Hypertens Rep 11: 167-172.
14. Raizada V, Skipper B, Luo W, Griffith J, (2007) Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects. J Investig Med 55: 341-359.
15. Paul M, Poyan Mehr A, Kreutz R, (2006) Physiology of Local Renin-Angiotensin Systems. Physiol Rev 86: 747-803.
16. Veerasingham SJ, Raizada MK, (2003) Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 139: 191-202.
17. Johnson AK, Thunhorst RL, (1997) The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 18: 292-353.
18. Xia H, Feng Y, Obr TD, Hickman PJ, Lazartigues E, (2009) Angiotensin II Type 1 Receptor-Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice. Hypertension 53: 210-216.
19. Feng Y, Yue X, Xia H, Bindom SM, Hickman PJ, et al. (2008) Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circ Res 102: 729-736.
20. Feng Y, Xia H, Santos RA, Speth R, Lazartigues E, (2010) Angiotensin-converting enzyme 2: a new target for neurogenic hypertension. Exp Physiol 95: 601-606.
21. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK, (2007) Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats. Hypertension 49: 926-931.
22. Xu P, Sriramula S, Lazartigues E, (2010) ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 300: R804-R817.
23. Kaiqiang J, Minakawa M, Fukui K, Suzuki Y, Fukuda I, (2009) Olmesartan improves left ventricular function in pressure-overload hypertrophied rat heart by blocking angiotensin II receptor with synergic effects of upregulation of angiotensin converting enzyme 2. Ther Adv Cardiovasc Dis 3: 103-111.
24. Lieb W, Graf J, Gotz A, Konig IR, Mayer B, et al. (2006) Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men Results of the MONICA Augsburg echocardiographic substudy. J Mol Med 84: 88-96.
25. Wang S, Fu C, Zou Y, Wang H, Shi Y, et al. (2008) Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy. Chin Med J 121: 27-31.
26. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL, (2004) Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216.
27. Esler M, Kaye D, (2000) Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 35: S1-S7.
28. Palatini P, (2001) Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease. Curr Hypertens Rep Suppl 1: s3-9.
29. Lijnen P, Petrov V, (1999) Renin-Angiotensin System, Hypertrophy and Gene Expression in Cardiac Myocytes. J Mol Cell Cardiol 31: 949-970.
30. Mehta PK, Griendling KK, (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-97.
31. González A, López B, Querejeta R, Díez J, (2002) Regulation of Myocardial Fibrillar Collagen by Angiotensin II. A Role in Hypertensive Heart Disease? J Mol Cell Cardiol 34: 1585-1593.
32. Matsusaka T, Katori H, Homma T, Ichikawa I, (1999) Mechanism of Cardiac Fibrosis by Angiotensin: New Insight Revealed by Genetic Engineering. Trends Cardiovasc Med 9: 180-184.
33. Pace L, Betocchi S, Losi M, Della Morte A, Ciampi Q, et al. (2004) Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function. Q J Nucl Med Mol Imaging 48: 20-25.
34. Limbruno U, Strata G, Zucchi R, Baglini R, Mengozzi G, et al. (1998) Altered autonomic cardiac control in hypertrophic cardiomyopathy: Role of outflow tract obstruction and myocardial hypertrophy. Eur Heart J 19: 146-153.
35. Yamazaki T, Komuro I, Yazaki Y, (1998) Signalling Pathways for Cardiac Hypertrophy. Cell Signal 10: 693-698.
36. Yamazaki T, Yazaki Y, (2000) Molecular basis of cardiac hypertrophy. Z Kardiol 89: 1-6.
37. Zucker IH, Wang W, Brandle M, Schultz HD, Patel KP, (1995) Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis 37: 397-414.
38. Zucker I, Liu J, (2000) Angiotensin II-nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail Rev 5: 27-43.
39. Zimmer H, (1997) Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J Mol Med 75: 849-850.
40. Leenen F, (1999) Cardiovascular consequences of sympathetic hyperactivity. Can J Cardiol Suppl A: 2A-7A.